HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of long-term, low-fat diet on plasma apo E in familial LCAT deficiency.

Abstract
To study the metabolic abnormalities in familial lecithin-cholesterol acyltransferase (LCAT) deficiency, the effects of a long-term, low-fat diet and LCAT replacement therapy on plasma lipids and apolipoproteins were investigated in a patient with LCAT deficiency. The patient had elevated triglycerides (TG, 543.7 mg/dl) and phospholipids (PL, 350.3 mg/dl) and normal total cholesterol (TC, 206.9 mg/dl). Change to a low-fat diet reduced TC and TG by 20% and 75%, respectively. These reductions occurred mainly in the d < 1.006 fraction. At baseline, the patient had normal apolipoprotein B (apo B), low apolipoprotein A-I (apoA-I) and apolipoprotein A-II (apoA-II) and elevated apolipoprotein E (apo E). Long-term treatment with a low-fat diet increased plasma apoA-I and decreased apo E. However, urinary protein excretion did not change throughout the observed period. LCAT replacement with fresh frozen plasma (FFP) after the low-fat diet further reduced plasma apo E to the normal range. These results indicate that the elevated plasma apo E in LCAT deficiency was related not only to the lack of LCAT in the plasma, but also to fat intake. A low-fat diet may be effective in correcting lipid abnormalities. Moreover, plasma apo E may be a good indicator of the efficacy of diet therapy.
AuthorsS Homma, N Murayama, T Kodama, N Yamada, K Takahashi, Y Asano, S Hosoda, T Murase, Y Akanuma
JournalNihon Jinzo Gakkai shi (Nihon Jinzo Gakkai Shi) Vol. 35 Issue 8 Pg. 999-1006 (Aug 1993) ISSN: 0385-2385 [Print] Japan
PMID8255012 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Apolipoproteins E
  • Dietary Fats
  • Phosphatidylcholine-Sterol O-Acyltransferase
Topics
  • Apolipoproteins E (analysis)
  • Dietary Fats (administration & dosage)
  • Humans
  • Lecithin Cholesterol Acyltransferase Deficiency (blood, diet therapy)
  • Male
  • Middle Aged
  • Phosphatidylcholine-Sterol O-Acyltransferase (administration & dosage)
  • Plasma

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: